Management of Severe Hypoglycemia
Patient Selection for Glucagon Therapy
- The American Diabetes Association, American Association of Clinical Endocrinologists, and American College of Physicians recommend glucagon for patients taking insulin, sulfonylureas, or glinides who are at high risk of hypoglycemia, including those with a history of severe hypoglycemia episodes or hypoglycemia unawareness 1, 2, 3
Glucagon Administration and Dosage
- The recommended dose of glucagon is 1 mg injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks, with the exact dosage varying depending on the patient's condition and healthcare provider's judgment 1
Training and Education
- The American Diabetes Association, American Correctional Association, and American College of Physicians recommend training family members, close associates, and caregivers on glucagon administration, storage requirements, recognition of severe hypoglycemia, and when to call emergency services 1, 2, 3, 4, 5
Monitoring and Follow-up
- After glucagon administration, blood glucose should be monitored, and if hypoglycemia persists after 15 minutes, a repeat dose may be administered while awaiting emergency assistance, with oral carbohydrates provided once the patient is alert to prevent recurrent hypoglycemia 1, 4, 6
Special Considerations
- Newer formulations of glucagon, such as nasal glucagon, single-dose auto-injector glucagon, and dasiglucagon pens, are preferred due to ease of use and should be considered for patients at high risk of hypoglycemia, with the American Diabetes Association and American Association of Clinical Endocrinologists recommending their use 4, 6, 2
- Glucagon is indicated for the treatment of severe hypoglycemia in individuals who cannot or will not consume carbohydrates orally, with a maximum effect at approximately 30 minutes after injection, and should be administered with caution in patients with impaired liver function 4, 6, 1
- The American Diabetes Association emphasizes the importance of educating individuals close to the patient on the storage, administration, and indications of glucagon, as well as the importance of never administering insulin to individuals with hypoglycemia, and recommends replacing glucagon products when they reach their expiration date and storing them according to specific product instructions 4, 5